GENinCode Plc (AIM:GENI)
0.8150
+0.0150 (1.88%)
Jul 27, 2026, 4:24 PM GMT
GENinCode Revenue
In the year 2025, GENinCode had annual revenue of 3.08M GBP with 13.88% growth. GENinCode had revenue of 1.47M in the half year ending December 31, 2025, with 21.82% growth.
Revenue
3.08M
Revenue Growth
+13.88%
P/S Ratio
2.02
Revenue / Employee
69.91K
Employees
44
Market Cap
6.21M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.08M | 375.00K | 13.88% |
| Dec 31, 2024 | 2.70M | 541.00K | 25.05% |
| Dec 31, 2023 | 2.16M | 730.00K | 51.05% |
| Dec 31, 2022 | 1.43M | 276.00K | 23.92% |
| Dec 31, 2021 | 1.15M | 193.00K | 20.08% |
| Dec 31, 2020 | 961.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 46.25B |
| GSK plc | 32.78B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Surgical Innovations Group | 11.60M |
| Proteome Sciences | 3.76M |
| Verici Dx | 2.72M |
| Oxford BioDynamics | 1.20M |
GENinCode News
- 6 weeks ago - Full Year 2025 Genincode PLC Earnings Presentation (Q&A) Transcript - GuruFocus
- 7 weeks ago - AIM Market Roundup: Marechale Capital, Genincode, Boohoo - The Armchair Trader
- 5 months ago - AIM Market Roundup: Phoenix Copper, Pipehawk, Genincode - The Armchair Trader
- 6 months ago - AIM Market Roundup: Eurasia Mining, Kitwave, Strategic Minerals - The Armchair Trader
- 8 months ago - Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening - Benzinga
- 8 months ago - AIM Market Roundup: Genincode, Proteome Sciences, Caspian Sunrise - The Armchair Trader
- 10 months ago - Half Year 2025 Genincode PLC Earnings Presentation Transcript - GuruFocus
- 11 months ago - AIM Market Roundup: Mosman Oil, Tekcapital, ECR Minerals - The Armchair Trader